KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gilead Sciences (GILD) Cash & Current Investments (2016 - 2025)

Historic Cash & Current Investments for Gilead Sciences (GILD) over the last 17 years, with Q3 2025 value amounting to $7.3 billion.

  • Gilead Sciences' Cash & Current Investments rose 4590.03% to $7.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $7.3 billion, marking a year-over-year increase of 4590.03%. This contributed to the annual value of $10.0 billion for FY2024, which is 3754.13% up from last year.
  • Latest data reveals that Gilead Sciences reported Cash & Current Investments of $7.3 billion as of Q3 2025, which was up 4590.03% from $5.2 billion recorded in Q2 2025.
  • In the past 5 years, Gilead Sciences' Cash & Current Investments ranged from a high of $10.0 billion in Q4 2024 and a low of $2.8 billion during Q2 2024
  • For the 5-year period, Gilead Sciences' Cash & Current Investments averaged around $6.2 billion, with its median value being $5.9 billion (2023).
  • Per our database at Business Quant, Gilead Sciences' Cash & Current Investments plummeted by 7606.67% in 2021 and then skyrocketed by 8805.92% in 2025.
  • Over the past 5 years, Gilead Sciences' Cash & Current Investments (Quarter) stood at $6.5 billion in 2021, then dropped by 2.07% to $6.4 billion in 2022, then increased by 13.77% to $7.3 billion in 2023, then skyrocketed by 37.54% to $10.0 billion in 2024, then dropped by 26.44% to $7.3 billion in 2025.
  • Its Cash & Current Investments stands at $7.3 billion for Q3 2025, versus $5.2 billion for Q2 2025 and $7.9 billion for Q1 2025.